PDF herunterladen
Am J Perinatol 2018; 35(13): 1260-1270
DOI: 10.1055/s-0038-1642033
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Antenatal Vitamin D Preserves Placental Vascular and Fetal Growth in Experimental Chorioamnionitis Due to Intra-amniotic Endotoxin Exposure

Michael W. Cookson
1   Section of Neonatology, The Pediatric Heart Lung Center, University of Colorado Anschutz Medical Center, Aurora, Colorado
,
Sharon L. Ryan
1   Section of Neonatology, The Pediatric Heart Lung Center, University of Colorado Anschutz Medical Center, Aurora, Colorado
2   Section of Neonatology, University of Colorado Anschutz Medical Center, Aurora, Colorado
,
Gregory J. Seedorf
1   Section of Neonatology, The Pediatric Heart Lung Center, University of Colorado Anschutz Medical Center, Aurora, Colorado
3   Section of Pulmonary Medicine, Department of Pediatrics, University of Colorado Anschutz Medical Center, Aurora, Colorado
,
R. Blair Dodson
1   Section of Neonatology, The Pediatric Heart Lung Center, University of Colorado Anschutz Medical Center, Aurora, Colorado
4   Department of United Therapeutics, Regenerative Medicine Lab, Durham, North Carolina
,
Steve H. Abman
1   Section of Neonatology, The Pediatric Heart Lung Center, University of Colorado Anschutz Medical Center, Aurora, Colorado
3   Section of Pulmonary Medicine, Department of Pediatrics, University of Colorado Anschutz Medical Center, Aurora, Colorado
,
Erica W. Mandell
1   Section of Neonatology, The Pediatric Heart Lung Center, University of Colorado Anschutz Medical Center, Aurora, Colorado
2   Section of Neonatology, University of Colorado Anschutz Medical Center, Aurora, Colorado
› Institutsangaben Funding This study was funded by Gilead Sciences Research Scholars Program, Section of Neonatology, University of Colorado.
Weitere Informationen

Publikationsverlauf

22. Januar 2018

23. Februar 2018

Publikationsdatum:
01. Mai 2018 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Abstract

Background Chorioamnionitis (CA) is associated with a high risk for the development of bronchopulmonary dysplasia (BPD) after preterm birth, but mechanisms that increase susceptibility for BPD and strategies to prevent BPD are uncertain. As a model of CA, antenatal intra-amniotic (IA) endotoxin (ETX) exposure alters placental structure, causes fetal growth restriction, increases perinatal mortality, and causes sustained cardiorespiratory abnormalities throughout infancy. Vitamin D (Vit D) has been shown to have both anti-inflammatory and proangiogenic properties. Antenatal IA treatment with Vit D (1,25-(OH)2D3) during IA ETX exposure improves survival and increases vascular and alveolar growth in infant rats. Whether IA ETX causes decreased placental vascular development and if the protective effects of prenatal Vit D treatment are due to direct effects on the fetus or to improved placental vascular development remain unknown.

Objective The objective of this study was to determine if IA ETX impairs placental vascular development and Vit D metabolism, and whether 1,25-(OH)2D3 treatment improves placental vascularity after IA ETX exposure during late gestation in pregnant rats.

Design/Methods Fetal rats were exposed to ETX (10 mg), ETX + 1,25-(OH)2D3 (1 ng/mL), 1,25-(OH)2D3 (1 ng/mL), or saline (control) via IA injection at E20 and delivered 2 days later. To assess placental vascular development, histologic sections from the placenta were stained for CD31 and vessel density per high power field (HPF) was determined and analyzed using Matlab software. To determine the effects of ETX on placental Vit D metabolism, Vit D receptor (VDR) and activity of the Vit D conversion enzyme, CYP27B1, were assayed from placental homogenates. Angiogenic mediators were measured by reverse transcription polymerase chain reaction by RNA extracted from placental tissue.

Results IA ETX reduced placenta and newborn birth weights by 22 and 20%, respectively, when compared with controls (placental weight: 0.60 vs. 0.47 g; p < 0.0001; birth weight: 4.68 vs. 5.88 g; p < 0.0001). IA 1,25-(OH)2D3 treatment increased birth weight by 12% in ETX-exposed pups (5.25 vs. 4.68 g; p < 0.001). IA ETX decreased placental vessel density by 24% in comparison with controls (1,114 vs. 848 vessels per HPF; p < 0.05). Treatment with IA 1,25-(OH)2D3 increased placenta vessel density twofold after ETX exposure (1,739 vs. 848); p < 0.0001), and increased vessel density compared with saline controls by 56% (1,739 vs. 1,114; p < 0.0001). IA ETX decreased both VDR and CYP27B1 expression by 83 and 35%, respectively (p < 0.01).

Conclusion IA ETX decreases placental growth and vessel density and decreases placental VDR and CYP27B1 protein expression, and that antenatal 1,25-(OH)2D3 restores placental weight and vessel density, as well as birth weight. We speculate that 1,25-(OH)2D3 treatment preserves placental function in experimental CA and that these effects may be mediated by increased vascular growth.

Keywords

vitamin D - endotoxin - placenta - chorioamnionitis - angiogenesis

Authors' Contributions

Conception and design: all authors. Drafting of article: E.W.M., S.R., M.W.C., and S.H.A. Analysis and data interpretation: E.W.M., M.W.C., and S.H.A.


 

  • References

  • 1 Stoll BJ, Hansen NI, Bell EF. , et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA 2015; 314 (10) 1039-1051
    CrossrefPubMedGoogle Scholar
  • 2 Slaughter JL, Pakrashi T, Jones DE, South AP, Shah TA. Echocardiographic detection of pulmonary hypertension in extremely low birth weight infants with bronchopulmonary dysplasia requiring prolonged positive pressure ventilation. J Perinatol 2011; 31 (10) 635-640
    CrossrefPubMedGoogle Scholar
  • 3 Bhat R, Salas AA, Foster C, Carlo WA, Ambalavanan N. Prospective analysis of pulmonary hypertension in extremely low birth weight infants. Pediatrics 2012; 129 (03) e682-e689
    CrossrefPubMedGoogle Scholar
  • 4 Abman SH, Collaco JM, Shepherd EG. , et al; Bronchopulmonary Dysplasia Collaborative. Interdisciplinary care of children with severe bronchopulmonary dysplasia. J Pediatr 2017; 181: 12-28
    CrossrefPubMedGoogle Scholar
  • 5 Mestan KK, Check J, Minturn L. , et al. Placental pathologic changes of maternal vascular underperfusion in bronchopulmonary dysplasia and pulmonary hypertension. Placenta 2014; 35 (08) 570-574
    CrossrefPubMedGoogle Scholar
  • 6 Mestan KK, Gotteiner N, Porta N, Grobman W, Su EJ, Ernst LM. Cord blood biomarkers of placental maternal vascular underperfusion predict bronchopulmonary dysplasia-associated pulmonary hypertension. J Pediatr 2017; 185: 33-41
    CrossrefPubMedGoogle Scholar
  • 7 Cotechini T, Hopman WJ, Graham CH. Inflammation-induced fetal growth restriction in rats is associated with altered placental morphometrics. Placenta 2014; 35 (08) 575-581
    CrossrefPubMedGoogle Scholar
  • 8 Kallapur SG, Bachurski CJ, Le Cras TD, Joshi SN, Ikegami M, Jobe AH. Vascular changes after intra-amniotic endotoxin in preterm lamb lungs. Am J Physiol Lung Cell Mol Physiol 2004; 287 (06) L1178-L1185
    CrossrefPubMedGoogle Scholar
  • 9 Tang JR, Seedorf GJ, Muehlethaler V. , et al. Moderate postnatal hyperoxia accelerates lung growth and attenuates pulmonary hypertension in infant rats after exposure to intra-amniotic endotoxin. Am J Physiol Lung Cell Mol Physiol 2010; 299 (06) L735-L748
    CrossrefPubMedGoogle Scholar
  • 10 Kramer BW, Kramer S, Ikegami M, Jobe AH. Injury, inflammation, and remodeling in fetal sheep lung after intra-amniotic endotoxin. Am J Physiol Lung Cell Mol Physiol 2002; 283 (02) L452-L459
    CrossrefPubMedGoogle Scholar
  • 11 Prince LS, Dieperink HI, Okoh VO, Fierro-Perez GA, Lallone RL. Toll-like receptor signaling inhibits structural development of the distal fetal mouse lung. Dev Dyn 2005; 233 (02) 553-561
    CrossrefPubMedGoogle Scholar
  • 12 Tang JR, Karumanchi SA, Seedorf G, Markham N, Abman SH. Excess soluble vascular endothelial growth factor receptor-1 in amniotic fluid impairs lung growth in rats: linking preeclampsia with bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2012; 302 (01) L36-L46
    CrossrefPubMedGoogle Scholar
  • 13 Mandell E, Seedorf GJ, Gien J, Abman SH. Vitamin D treatment improves survival and infant lung structure after intra-amniotic endotoxin exposure in rats: potential role for the prevention of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2014; 306 (05) L420-L428
    CrossrefPubMedGoogle Scholar
  • 14 Van Marter LJ, Dammann O, Allred EN. , et al; Developmental Epidemiology Network Investigators. Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants. J Pediatr 2002; 140 (02) 171-176
    CrossrefPubMedGoogle Scholar
  • 15 Watterberg KL, Demers LM, Scott SM, Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996; 97 (02) 210-215
    PubMedGoogle Scholar
  • 16 Mandell E, Seedorf GJ, Ryan S, Gien J, Cramer SD, Abman SH. Antenatal endotoxin disrupts lung vitamin D receptor and 25-hydroxyvitamin D 1α-hydroxylase expression in the developing rat. Am J Physiol Lung Cell Mol Physiol 2015; 309 (09) L1018-L1026
    CrossrefPubMedGoogle Scholar
  • 17 Brannon PM. Vitamin D and adverse pregnancy outcomes: beyond bone health and growth. Proc Nutr Soc 2012; 71 (02) 205-212
    CrossrefPubMedGoogle Scholar
  • 18 Liu NQ, Hewison M. Vitamin D, the placenta and pregnancy. Arch Biochem Biophys 2012; 523 (01) 37-47
    CrossrefPubMedGoogle Scholar
  • 19 Liu NQ, Ouyang Y, Bulut Y. , et al. Dietary vitamin D restriction in pregnant female mice is associated with maternal hypertension and altered placental and fetal development. Endocrinology 2013; 154 (07) 2270-2280
    CrossrefPubMedGoogle Scholar
  • 20 Olmos-Ortiz A, Avila E, Durand-Carbajal M, Díaz L. Regulation of calcitriol biosynthesis and activity: focus on gestational vitamin D deficiency and adverse pregnancy outcomes. Nutrients 2015; 7 (01) 443-480
    CrossrefPubMedGoogle Scholar
  • 21 Bodnar LM, Klebanoff MA, Gernand AD. , et al. Maternal vitamin D status and spontaneous preterm birth by placental histology in the US Collaborative Perinatal Project. Am J Epidemiol 2014; 179 (02) 168-176
    CrossrefPubMedGoogle Scholar
  • 22 Gernand AD, Simhan HN, Caritis S, Bodnar LM. Maternal vitamin D status and small-for-gestational-age offspring in women at high risk for preeclampsia. Obstet Gynecol 2014; 123 (01) 40-48
    CrossrefPubMedGoogle Scholar
  • 23 Bodnar LM, Catov JM, Simhan HN, Holick MF, Powers RW, Roberts JM. Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab 2007; 92 (09) 3517-3522
    CrossrefPubMedGoogle Scholar
  • 24 Urrutia RP, Thorp JM. Vitamin D in pregnancy: current concepts. Curr Opin Obstet Gynecol 2012; 24 (02) 57-64
    CrossrefPubMedGoogle Scholar
  • 25 Devereux G, Litonjua AA, Turner SW. , et al. Maternal vitamin D intake during pregnancy and early childhood wheezing. Am J Clin Nutr 2007; 85 (03) 853-859
    CrossrefPubMedGoogle Scholar
  • 26 Camargo Jr CA, Ingham T, Wickens K. , et al; New Zealand Asthma and Allergy Cohort Study Group. Cord-blood 25-hydroxyvitamin D levels and risk of respiratory infection, wheezing, and asthma. Pediatrics 2011; 127 (01) e180-e187
    CrossrefPubMedGoogle Scholar
  • 27 Brehm JM, Celedón JC, Soto-Quiros ME. , et al. Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica. Am J Respir Crit Care Med 2009; 179 (09) 765-771
    CrossrefPubMedGoogle Scholar
  • 28 Liu NQ, Kaplan AT, Lagishetty V. , et al. Vitamin D and the regulation of placental inflammation. J Immunol 2011; 186 (10) 5968-5974
    CrossrefPubMedGoogle Scholar
  • 29 Hewison M. An update on vitamin D and human immunity. Clin Endocrinol (Oxf) 2012; 76 (03) 315-325
    CrossrefPubMedGoogle Scholar
  • 30 Hewison M, Gacad MA, Lemire J, Adams JS. Vitamin D as a cytokine and hematopoetic factor. Rev Endocr Metab Disord 2001; 2 (02) 217-227
    CrossrefPubMedGoogle Scholar
  • 31 Gray TK, Lester GE, Lorenc RS. Evidence for extra-renal 1 alpha-hydroxylation of 25-hydroxyvitamin D3 in pregnancy. Science 1979; 204 (4399): 1311-1313
    CrossrefPubMedGoogle Scholar
  • 32 Weisman Y, Harell A, Edelstein S, David M, Spirer Z, Golander A. 1 alpha, 25-Dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 in vitro synthesis by human decidua and placenta. Nature 1979; 281 (5729): 317-319
    CrossrefPubMedGoogle Scholar
  • 33 Zehnder D, Evans KN, Kilby MD. , et al. The ontogeny of 25-hydroxyvitamin D(3) 1alpha-hydroxylase expression in human placenta and decidua. Am J Pathol 2002; 161 (01) 105-114
    CrossrefPubMedGoogle Scholar
  • 34 Evans KN, Bulmer JN, Kilby MD, Hewison M. Vitamin D and placental-decidual function. J Soc Gynecol Investig 2004; 11 (05) 263-271
    CrossrefPubMedGoogle Scholar
  • 35 Novakovic B, Sibson M, Ng HK. , et al. Placenta-specific methylation of the vitamin D 24-hydroxylase gene: implications for feedback autoregulation of active vitamin D levels at the fetomaternal interface. J Biol Chem 2009; 284 (22) 14838-14848
    CrossrefPubMedGoogle Scholar
  • 36 Paulson SK, Ford KK, Langman CB. Pregnancy does not alter the metabolic clearance of 1,25-dihydroxyvitamin D in rats. Am J Physiol 1990; 258 (1 Pt 1): E158-E162
    PubMedGoogle Scholar
  • 37 Delvin EE, Gilbert M, Pere MC, Garel JM. In vivo metabolism of calcitriol in the pregnant rabbit doe. J Dev Physiol 1988; 10 (05) 451-459
    PubMedGoogle Scholar
  • 38 Weisman Y, Vargas A, Duckett G, Reiter E, Root AW. Synthesis of 1,25-dihydroxyvitamin D in the nephrectomized pregnant rat. Endocrinology 1978; 103 (06) 1992-1996
    CrossrefPubMedGoogle Scholar
  • 39 Bouillon R, Van Assche FA, Van Baelen H, Heyns W, De Moor P. Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3. Significance of the free 1,25-dihydroxyvitamin D3 concentration. J Clin Invest 1981; 67 (03) 589-596
    CrossrefPubMedGoogle Scholar
  • 40 Kumar R, Cohen WR, Silva P, Epstein FH. Elevated 1,25-dihydroxyvitamin D plasma levels in normal human pregnancy and lactation. J Clin Invest 1979; 63 (02) 342-344
    CrossrefPubMedGoogle Scholar
  • 41 O'Brien KO, Li S, Cao C. , et al. Placental CYP27B1 and CYP24A1 expression in human placental tissue and their association with maternal and neonatal calcitropic hormones. J Clin Endocrinol Metab 2014; 99 (04) 1348-1356
    CrossrefPubMedGoogle Scholar
  • 42 Cardus A, Panizo S, Encinas M. , et al. 1,25-dihydroxyvitamin D3 regulates VEGF production through a vitamin D response element in the VEGF promoter. Atherosclerosis 2009; 204 (01) 85-89
    CrossrefPubMedGoogle Scholar
  • 43 Zehnder D, Bland R, Chana RS. , et al. Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. J Am Soc Nephrol 2002; 13 (03) 621-629
    PubMedGoogle Scholar
  • 44 Grundmann M, Haidar M, Placzko S. , et al. Vitamin D improves the angiogenic properties of endothelial progenitor cells. Am J Physiol Cell Physiol 2012; 303 (09) C954-C962
    CrossrefPubMedGoogle Scholar
  • 45 Mainigi MA, Olalere D, Burd I, Sapienza C, Bartolomei M, Coutifaris C. Peri-implantation hormonal milieu: elucidating mechanisms of abnormal placentation and fetal growth. Biol Reprod 2014; 90 (02) 26
    PubMedGoogle Scholar
  • 46 Shin JS, Choi MY, Longtine MS, Nelson DM. Vitamin D effects on pregnancy and the placenta. Placenta 2010; 31 (12) 1027-1034
    CrossrefPubMedGoogle Scholar
  • 47 Miliku K, Mesu A, Franco OH, Hofman A, Steegers EAP, Jaddoe VWV. Maternal and fetal folate, vitamin B12, and homocysteine concentrations and childhood kidney outcomes. Am J Kidney Dis 2017; 69 (04) 521-530
    CrossrefPubMedGoogle Scholar
  • 48 Check J, Gotteiner N, Liu X. , et al. Fetal growth restriction and pulmonary hypertension in premature infants with bronchopulmonary dysplasia. J Perinatol 2013; 33 (07) 553-557
    CrossrefPubMedGoogle Scholar
  • 49 Mourani PM, Abman SH. Pulmonary hypertension and vascular abnormalities in bronchopulmonary dysplasia. Clin Perinatol 2015; 42 (04) 839-855
    CrossrefPubMedGoogle Scholar
  • 50 Chen YY, Powell TL, Jansson T. 1,25-Dihydroxy vitamin D3stimulates system A amino acid transport in primary human trophoblast cells. Mol Cell Endocrinol 2017; 442: 90-97
    CrossrefPubMedGoogle Scholar
  • 51 Gaccioli F, Lager S, Powell TL, Jansson T. Placental transport in response to altered maternal nutrition. J Dev Orig Health Dis 2013; 4 (02) 101-115
    CrossrefPubMedGoogle Scholar
  • 52 Delvin EE, Gagnon L, Arabian A, Gibb W. Influence of calcitriol on prolactin and prostaglandin production by human decidua. Mol Cell Endocrinol 1990; 71 (03) 177-183
    CrossrefPubMedGoogle Scholar
  • 53 Ross R, Florer J, Halbert K, McIntyre L. Characterization of 1,25-dihydroxyvitamin D3 receptors and in vivo targeting of [3H]-1,25(OH)2D3 in the sheep placenta. Placenta 1989; 10 (06) 553-567
    CrossrefPubMedGoogle Scholar
  • 54 Hillman NH, Polglase GR, Pillow JJ, Saito M, Kallapur SG, Jobe AH. Inflammation and lung maturation from stretch injury in preterm fetal sheep. Am J Physiol Lung Cell Mol Physiol 2011; 300 (02) L232-L241
    CrossrefPubMedGoogle Scholar
  • 55 Jobe AH. Effects of chorioamnionitis on the fetal lung. Clin Perinatol 2012; 39 (03) 441-457
    CrossrefPubMedGoogle Scholar
  • 56 Miller JD, Benjamin JT, Kelly DR, Frank DB, Prince LS. Chorioamnionitis stimulates angiogenesis in saccular stage fetal lungs via CC chemokines. Am J Physiol Lung Cell Mol Physiol 2010; 298 (05) L637-L645
    CrossrefPubMedGoogle Scholar
  • 57 Mandell E, Powers KN, Harral JW. , et al. Intrauterine endotoxin-induced impairs pulmonary vascular function and right ventricular performance in infant rats and improvement with early vitamin D therapy. Am J Physiol Lung Cell Mol Physiol 2015; 309 (12) L1438-L1446
    CrossrefPubMedGoogle Scholar
  • 58 Chung I, Han G, Seshadri M. , et al. Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo. Cancer Res 2009; 69 (03) 967-975
    CrossrefPubMedGoogle Scholar
  • 59 Bao BY, Yao J, Lee YF. 1alpha, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis. Carcinogenesis 2006; 27 (09) 1883-1893
    CrossrefPubMedGoogle Scholar
  • 60 Ben-Shoshan M, Amir S, Dang DT, Dang LH, Weisman Y, Mabjeesh NJ. 1alpha,25-dihydroxyvitamin D3 (Calcitriol) inhibits hypoxia-inducible factor-1/vascular endothelial growth factor pathway in human cancer cells. Mol Cancer Ther 2007; 6 (04) 1433-1439
    PubMedGoogle Scholar
  • 61 Ma Y, Johnson CS, Trump DL. Mechanistic insights of vitamin D anticancer effects. Vitam Horm 2016; 100: 395-431
    PubMedGoogle Scholar
  • 62 Mantell DJ, Owens PE, Bundred NJ, Mawer EB, Canfield AE. 1 alpha,25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo. Circ Res 2000; 87 (03) 214-220
    CrossrefPubMedGoogle Scholar
  • 63 Gui J, Rohrbach A, Borns K. , et al. Vitamin D rescues dysfunction of fetal endothelial colony forming cells from individuals with gestational diabetes. Placenta 2015; 36 (04) 410-418
    CrossrefPubMedGoogle Scholar
  • 64 Battaglia FC, Meschia G. An Introduction to Fetal Physiology. Orlando: Academic Press; 1986
    Google Scholar